NEWARK, Del, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The global Therapeutic Apheresis Market is poised for a CAGR of 6.8% over the forecast period. With a projected value of US$ 2,717.9 million in 2023, the market's influence is set to double, reaching an impressive US$ 5,264.4 million by 2033. This substantial expansion underscores the increasing demand for therapeutic apheresis solutions worldwide."
The rising prevalence of diseases, increased demand for blood components, and the safety that goes along with them are the key components for market growth. Moreover, technological advancements in creating new apheresis techniques and increasing reimbursement policies and funding are market-driving forces.
In addition, the market expansion is anticipated to be fueled by the increased incidence of blood-related illnesses, the availability of supportive government initiatives, and reimbursement frameworks. Moreover, it is projected that the demand for apheresis equipment will be supported throughout the forecast period by the increased popularity and involvement in blood donation campaigns and camps and the rising number of blood transfusions.
Request Your Sample Report for more insights into the Therapeutic Apheresis Market: https://www.futuremarketinsights.com/reports/sample/rep-gb-5863
The expansion of the North American therapeutic apheresis market is anticipated to be constrained by the need for more donor availability and histocompatibility. For instance, barely 3% of Americans give blood, according to a June 2019 article from the American Red Cross.
Therapeutic Apheresis Market Key Takeaways
- By 2033, the therapeutic apheresis market in the United Kingdom will likely expand, with a CAGR of 4.8%.
- In 2022, the United States developed the therapeutic apheresis business with a share of 28.8%.
- The therapeutic apheresis market grew considerably to US$ 2,577.9 million in 2022.
- The therapeutic apheresis sector expanded at a CAGR of 4.4% from 2018 to 2022.
- By 2033, China's therapeutic apheresis market is projected to develop with a CAGR of 8.3%.
- By 2033, India's therapeutic apheresis industry is projected to expand with a CAGR of 6.8%.
- Japan's therapeutic apheresis industry grew significantly, with a 4.2% share in 2022.
- Australia's therapeutic apheresis market is likely to expand with a CAGR of 6.1% by 2033.
- Germany's therapeutic apheresis business grew, with a share of 6.3% in 2022.
- In 2022, based on the technology, centrifugation dominated the market, with a share of 58.3%.
- In 2022, the blood bank segment dominated the market, with a share of 43.5%, based on end users.
Therapeutic Apheresis Market Competitors and Their Winning Strategies
The market has currently demonstrated budding success and is well-established in several locations. As a result of growing government activities, more individuals are becoming aware of the industry under study, fueling its expansion. Strategic partnerships and new product launches by large corporations are also anticipated to fuel market expansion.
Open the door to strategic insights through our methodology today: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5863
Top 13 Players in Therapeutic Apheresis Market:
- Asahi Kasei Medical Co.
- Haemonetics Corporation
- Miltenyi Biotec
- Cerus Corporation
- Terumo BCT Inc.
- Fresenius Kabi USA
- Terumo Bct
- B. Braun Melsungen AG
- Nikkiso Co. Ltd.
- Medica S.p.A.
- Baxter Healthcare Corporation
- Kawasumi Laboratories Inc.
- Therakos Incorporation
Therapeutic Apheresis Market Recent Developments:
- Toray Medical Co. Ltd. (Japan) introduced the TORAYMYXIN medical device to the European market in June 2019.
- Baxter International Inc. (United States) introduced the PrisMax system in the US in July 2019.
- In June 2022, Terumo Blood and Cell Technologies announced that the automated red blood cell exchange procedure performed on the company's Spectra Optia Apheresis System had been selected by the NHS MedTech Funding Mandate (MTFM) programme in NHS England in the United Kingdom to treat sickle cell disease.
- In July 2022, Eliaz Therapeutics and Terumo Blood and Cell Technologies worked together to create and market a breakthrough therapeutic apheresis therapy for acute renal damage (AKI).
Buy Now: https://www.futuremarketinsights.com/checkout/5863
Therapeutic Apheresis Market Key Segments
By Procedure Types:
- Therapeutic Plasma Exchange (TPE)
- Red Blood Cell Exchange (RBCX)
- Cellular Depletions
By Technology:
- Centrifugation
- Membrane filtration
By Application:
- Hematology
- Neurology
- Nephrology
- Rheumatology
- Oncology
- Others
By End User:
- Hospitals
- Blood banks
- Specialty clinics
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Have a Look at Trending Reports in the Healthcare Domain:
Hadron Therapy Market Size: Anticipated to attain a value of US$ 1.5 billion in 2023, the worldwide hadron therapy market is poised for remarkable growth, surging to US$ 4.7 billion by 2033. Projected at an impressive CAGR of 11.9% from 2023 to 2033, this marks a substantial increase from the 8% CAGR recorded from 2018 to 2022.
Onychomycosis Treatment Market Share: Anticipated at a value of US$ 4,738.3 million in 2023, the worldwide onychomycosis treatment market is poised for substantial expansion. Over the period from 2023 to 2033, the market is projected to achieve a noteworthy Compound Annual Growth Rate (CAGR) of 8.4%, reaching a total worth of US$ 10,608.8 million.
Single-use Bioreactors Market Demand: By 2033, the single-use bioreactors market is forecasted to attain a substantial worth of US$ 18.9 billion, with a projected valuation of US$ 4.5 billion by the conclusion of 2023. Notably, the market is expected to experience a noteworthy Compound Annual Growth Rate (CAGR) of 15.4% from 2023 to 2033.
Endoscopic Closure Systems Market Growth: The projected value of the worldwide endoscopic closure systems market for 2023 is estimated at approximately US$ 309.2 million, with a projected Compound Annual Growth Rate (CAGR) of 6.3%. It is expected to further rise and reach around US$ 570.2 million by the period between 2023 and 2033. Notably, from 2018 to 2022, the endoscopic closure systems sector demonstrated a steady expansion at a CAGR of 4.1%.
Knee Reconstruction Devices Market Sales: By 2023, the worldwide knee reconstruction devices market is projected to achieve a value of approximately US$ 8.5 billion, showing a steady growth rate with a 4.3% CAGR from 2023 to 2033. Furthermore, the market is poised to reach around US$ 13.0 billion by the end of 2033.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
